The neuroendocrinology of chronic fatigue syndrome

Endocrine Reviews

Volumn 24, Issue 2, 2003, Pages 236-252

  Cleare, Anthony J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DESMOPRESSIN; DEXFENFLURAMINE; DOPAMINE 2 RECEPTOR; FLUDROCORTISONE; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; LEPTIN; MELATONIN; MONOAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NALOXONE; NEUROTRANSMITTER; NORADRENALIN; OPIATE RECEPTOR; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; PYRIDOSTIGMINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; TETRACOSACTIDE;

ADRENAL CORTEX ATROPHY; ADRENAL GLAND; CEREBROSPINAL FLUID; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; FEEDBACK SYSTEM; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SLEEP DISORDER; THEORY;

EID: 0037396496     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0014     Document Type: Review

References (163)

1. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A 1994 The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121:953-959
2. Sharpe M, Archard L, Banatvala J, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP, Lane RJ, McDonald E, Mowbray J, Pearson D, Peto T, Preedy V, Smith A, Smith D, Taylor D, Tyrrell D, Wessely S, White P 1991 Chronic fatigue syndrome: guidelines for research. J R Soc Med 84:118-121
3. Lloyd A, Hickie I, Boughton R, Spencer O, Wakefield D 1990 Prevalence of chronic fatigue syndrome in an Australian Population. Med J Aust 153:522-528
4. Wessely S, Hotopf M, Sharpe M 1998 Chronic fatigue and its syndromes. Oxford, UK: Oxford University Press
5. Wessely S, Nimnuan C, Sharpe M 1999 Functional somatic syndromes: one or many? Lancet 354:936-939
6. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M 2001 How many functional somatic syndromes? J Psychosom Res 51:549-557
7. Dinan TG 1994 Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry 164:365-371
8. Gold PW, Licinio J, Wong ML, Chrousos GP 1995 Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci 771:716-729
9. Heim C, Ehlert U, Hellhammer DH 2000 The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25:1-35
10. Abelson JL, Curtis GC 1996 Hypothalamic-pituitary-adrenal axis activity in panic disorder. Arch Gen Psychiatry 53:323-331
11. Tattersall R 1999 Hypoadrenia, or "a bit of Addison's disease." Med Hist 43:450-457
12. Brosnan CM, Cowing NFC 1996 Addison's disease. Br Med J 312:1085-1087
13. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler BG 1987 The CRH test in the postoperative evaluation of patients with Cushing's syndrome. J Clin Endocrinol Metab 65:906-913
14. Riordain D, Farley D, Young W, Grant C, van Heerden J 1994 Long term outcome of bilateral adrenalectomy in patients with Cushing's syndrome. Surgery 116:1088-1093
15. Baxter JD, Tyrel JB 1981 The adrenal cortex. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and metabolism. New York: McGraw-Hill; 385-510
16. Poteliakhoff A 1981 Adrenocortical activity and some clinical findings in chronic fatigue. J Psychosom Res 25:91-95
17. Demitrack M, Dale J, Straus S, Laue L, Listwak S, Kruesi M, Chrousos G, Gold P 1991 Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73:1224-1234
18. Cleare AJ, Beam J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane V 1995 Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 34:283-289
19. Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A, Wessely S 1995 Neuroendocrine responses to D-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 37:245-252
20. Yatham L, Morehouse R, Chisholm B, Haase D, MacDonald D, Marrie T 1995 Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Can J Psychiatry 40:93-96
21. Dinan TG, Majeed T, Lavelle E, Scott LV, Berti C, Behan P 1997 Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 22:261-267
22. Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T 1998 Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1:143-146
23. Scott LV, Medbak S, Dinan TG 1998 Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 97:450-457
24. Scott LV, Medbak S, Dinan TG 1998 The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 48:733-737
25. Scott L, Burnett F, Medback S, Dinan T 1998 Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 28:285-293
26. Scott LV, Medbak S, Dinan TG 1999 Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biol Psychiatry 45:1447-1454
27. Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG 1999 Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 54:129-137
28. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ 2000 Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 85:692-696
29. van Rensburg SJ, Potocnik FC, Kiss T, Hugo F, van Zijl P, Mansvelt E, Carstens ME, Theodorou P, Hurly PR, Emsley RA, Taljaard JJ 2001 Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res Bull 55:319-325
30. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V 2001 Hypothalamo-pituitary-adrenal axis function in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 86:3545-3554
31. Ottenweller JE, Sisto SA, McCarty RC, Natelson BH 2001 Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 43:34-41
32. Gaab J, Huster D, Peisen R, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U 2002 Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological and pharmacological stimulation. Psychosom Med 64:951-962
33. Altemus M, Dale JK, Michelson D, Demitrack MA, Gold PW, Straus SE 2001 Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 26:175-188
34. Moorkens G, Berwaerts J, Wynants H, Abs R 2000 Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin Endocrinol (Oxf) 53:99-106
35. Hamilos DL, Nutter D, Gershtenson J, Redmond DP, Clementi JD, Schmaling KB, Make BJ, Jones JF 1998 Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatry 43:293-302
36. Racciatti D, Sensi S, De Remigis P, Barberio A, Sciascio T, Pizzigallo E 1998 Neuroendocrine aspects of chronic fatigue syndrome. Am J Med 104:1S-3S
37. MacHale SM, Cavanagh JT, Bennie J, Carroll S, Goodwin GM, Lawrie SM 1998 Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 38:213-217
38. Scott L, Dinan T 1998 Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 47:49-54
39. Cleare AJ, Blair D, Chambers S, Wessely S 2001 Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry 158:641-643
40. Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ 1998 Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 43:236-237
41. Wood B, Wessely S, Papadopoulos A, Poon L, Checkley S 1998 Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 37:1-4
42. Strickland P, Morriss R, Wearden A, Deakin W 1998 A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 47:191-194
43. Gaab J, Hüster D, Peisen R, Engert V, Schad T, Schürmeyer TH, Ehlert U 2002 The low dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 64:311-318
44. Thompson LM, Rubin RT, McCracken JT 1992 Neuroendocrine aspects of primary endogenous depression. 12. Receiver operating characteristics and kappa analyses of serum and urine cortisol measure in patients and matched controls. Psychoneuroendocrinology 17:507-515
45. Raven P, Taylor NF 1996 Sex differences in the human metabolism of cortisol. Endocr Res 22:751-755
46. Raven PW, Taylor NF 1998 11β-HSD and 17β-HSD as biological markers of depression: sex differences and correlation with symptom severity. Endocr Res 24:659-662
47. Murphy BEP 2002 Urinary free cortisol determinations: what they measure. Endocrinologist 12:143-150
48. Kirschbaum C, Hellhammer DH 1994 Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19:313-333
49. Harvey A, Purdie G, Bushnell J, Ellis P, Are cortisol levels low in chronic fatigue syndrome? A meta-analysis. Third International Clinical and Scientific Meeting on CFS/ME, Sydney, Australia, 2001
50. Holsboer F 1995 Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 957-969
51. Holmes G, Kaplan J, Gantz N, Komaroff A, Schonberger L, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Browh N, Schooles RT, Brus I 1988 Chronic fatigue syndrome: a working case definition. Ann Intern Med 108:387-389
52. Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, Spring SB, Landay A, Buchwald D 1992 NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Arm Intern Med 117:325-331
53. Antoni F 1993 Vasopressinergic control of pituitary adrenocorticotrophin secretion comes of age. Front Neuroendocrinol 14:76-122
54. Lamberts S, Verleun S, Oosteron R, DeJong F, Hackeng W 1984 Corticotrophin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man. J Clin Endocdnol Metab 58:298-303
55. DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Alexander AN, Vale W, Rivier J, Orth DN 1984 Arginine vasopressin potentiates adrenocorticotrophin release induced by corticotropin releasing factor. J Clin Invest 73:533-538
56. Salata RA, Jarrett DB, Verbalis JG, Robinson AG 1988 Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest 81:766-774
57. Bakheit AM, Behan PO, Watson WS, Morton JJ 1993 Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol Scand 87:234-238
58. Grinspoon SK, Biller BM 1994 Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79:923-931
59. Rasmuson S, Olsson T, Hagg E 1996 A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 44:151-156
60. Hudson M, Cleare AJ 1999 The 1microg short Synacthen test in chronic fatigue syndrome. Clin Endocrinol (Oxf) 51:625-630
61. Hyyppa M, Lindholm T, Lehtinen V, Puukka P 1993 Self-perceived fatigue and cortisol secretion in a community sample. J Psychosom Res 37:589-594
62. Poland RE, Lin K-M, Lutchmansingh P, McCracken JP, Biological markers in CFS and neurasthenia. X World Congress of Psychiatry, Madrid, Spain, 1996 (Abstracts, vol 1, p 184)
63. Lavelle E, Dinan TG, Hypothalamo-pituitary-adrenal axis function in chronic fatigue syndrome: a study of fast feedback mechanisms. Royal College of Surgeons of Ireland Research Meeting, Dublin, Ireland, 1996
64. Pruessner JC, Hellhammer DH, Kirschbaum C 1999 Burnout, perceived stress, and cortisol responses to awakening. Psychosom Med 61:197-204
65. Yehuda R, Boisoneau D, Lowy MT, Giller Jr EL 1995 Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52:583-593
66. Goenjian AK, Yehuda R, Pynoos RS, Steinberg AM, Tashjian M, Yang RK, Najarian LM, Fairbanks LA 1996 Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia. Am J Psychiatry 153:929-934
67. Stein MB, Yehuda R, Koverola C, Hanna C 1997 Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 42:680-686
68. Heim C, Ehlert U, Hanker JP, Hellhammer DH 1998 Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med 60:309-318
69. Visser J, Blauw B, Hinloopen B, Brommer E, deKloet E, Kluft C, Nagelkerken L 1998 CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-γ production and increased sensitivity to dexamethasone. J Infect Dis 177:451-454
70. Visser J, Lentjes E, Haspels I, Graffelman W, Blauw B, de Kloet R, Nagelkerken L 2001 Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors. J Investig Med 49:195-204
71. Majeed T, Dinan T, Thakore J, Gray C, Behan P 1995 Defective dexamethasone induced growth hormone release in chronic fatigue syndrome; evidence for glucocorticoid receptor resistance and lack of plasticity? Ir Coll Physicians Surgeons 24:20-24
72. Baulieu E-E 1996 Dehydroepiandrostenedione (DHEA): a fountain of youth? J Clin Endocrinol Metab 81:3147-3151
73. Barrett-Connor E, von Muhlen D, Laughlin GA, Kripke A 1999 Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc 47:685-691
74. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E 1999 Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156:646-649
75. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
76. De Becker P, De Meirleir K, Joos E, Campine I, Van Steenberge E, Smitz J, Velkeniers B 1999 Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm Metab Res 31:18-21
77. Scott LV, Svec F, Dinan T 2000 A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psych Res 97:21-28
78. Taylor T, Dluhy R, Williams G 1983 β-Endorphin suppresses adrenocor ticotrophin and cortisol levels in normal human subjects. J Clin Endocrinol Metab 57:592-596
79. Conti F, Pittoni V, Sacerdote P, Priori R, Meroni PL, Valesini G 1998 Decreased immunoreactive β-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol 16:729-732
80. Terenius L, Wahlstrom A 1978 Physiological and clinical relevance or endorphins. In: Hughes J, ed. Centrally acting peptides. Baltimore: Baltimore University Park Press; 161-178
81. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garica-Borreguero D, Blackwelder W, Straus SE 1998 Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 280:1061-1066
82. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J 1999 Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 353:455.458
83. Cleare AJ, Sookdeo S, Jones J, O'Keane V, Miell J 2001 Plasma leptin in chronic fatigue syndrome, and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion. Clin Endocrinol (Oxf) 55:113-119
84. Himmel P, Seligman T 1999 A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J Clin Rheumatol 5:56-59
85. Bou-Holaigah I, Rowe P, Kan J, Calkins H 1995 The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 274:961-967
86. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A, Haugland JM, Lambrecht LJ, Swan S, Goldsmith S 1998 A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 158:908-914
87. Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE 2001 Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285:52-59
88. Lawrie S, MacHale S, Power M, Goodwin G 1997 Is the chronic fatigue syndrome best understood as a primary disturbance of the sense of effort? Psychol Med 27:995.999
89. van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G 2000 Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res 49:373-379
90. Vercoulen JH, Bazelmans E, Swanink CM, Fennis JF, Galama JM, Jongen PJ, Hommes O, Van der Meer JW, Bleijenberg G 1997 Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 31:661-673
91. Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG 1999 Small adrenal glands in chronic fatigue syndrome: A preliminary computer tomography study. Psychoneuroendocrinology 24:759-768
92. Torpy DJ, Bachmann AW, Grice JE, Fitzgerald SP, Phillips PJ, Whitworth JA, Jackson RV 2001 Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J Clin Endocrinol Metab 86:3692-3700
93. Roy-Byrne P, Afari N, Ashton S, Fischer M, Goldberg J, Buchwald D 2002 Chronic fatigue and anxiety/depression: a twin study. Br J Psychiatry 180:29-34
94. Fleshner M, Deak T, Spencer RL, Laudenslager ML, Watkins LR, Maier SF 1995 A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure. Endocrinology 136:5336-5342
95. Schlecte JA, Hamilton D 1987 The effect of glucocorticoids on corticosteroid binding globulin. Clin Endocrinol (Oxf) 27:197-203
96. White PD, Thomas JM, Amess J, Crawford DH, Grover SA, Kangro HO, Clare AW 1998 Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 173:475-481
97. Candy B, Chalder T, Cleare AJ, Wessely S, Peakman M, Zuckerman M, Skowera A, Weinman J, Hotopf M, Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med, in press
98. De Bellis M, Chrousos G, Dora L, Burke L, Helmers K, Kling M, Trickett P, Putnam F 1994 Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab 78:249-255
99. Heim C, Newport DJ, Heit S, Graham YP, Wilcox M, Bonsall R, Miller AH, Nemeroff CB 2000 Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284:592-597
100. Spath Schwalbe E, Scholler T, Kern W, Fehm HL, Born J 1992 Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab 75:1431-1435
101. Leese G, Chattington P, Fraser W, Vora J, Edwards R, Williams G 1996 Short-term night-shift working mimics the pituitary-adrenocortical dysfunction of chronic fatigue syndrome. J Clin Endocrinol Metab 81:1867-1870
102. Stupnicki R, Obminski Z 1992 Glucocorticoid response to exercise as measured by serum and salivary cortisol. Eur J Appl Physiol 65:546-549
103. McCain G, Tilbe K 1989 Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol 16(Suppl 19):154-157
104. Crofford L, Pillemer S, Kalogeras K, Cash J, Michelson D, Kling M, Steinberg E, Gold P, Chrousos G, Wilder RL 1994 Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37:1583-1592
105. Lentjes EG, Griep EN, Boersma JW, Romijn FP, de Kloet ER 1997 Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 22:603-614
106. Maes M, Lin A, Bonaccorso S, van Hunsel F, Van Gastel A, Delmeire L, Biondi M, Bosmans E, Kenis G, Scharpe S 1998 Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psych Scand 98:328-335
107. Catley D, Kaell AT, Kirschbaum C, Stone AA 2000 A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res 13:51-61
108. van Denderen J, Boersma J, Zeinstra P, Hollander A, van Neerbos B 1992 Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity? Scand J Rheum 21:35-37
109. Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F 2001 A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf) 55:455-459
110. Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL 1999 Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106:534-543
111. Griep E, Boersma J, de Kloet R 1993 Altered reactivity of the hypothalamic-pituitary adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469-474
112. Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet E 1998 Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 25:1374-1381
113. Riedel W, Schlapp U, Leck S, Netter P, Neeck G 2002 Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Ann NY Acad Sci 966:483-490
114. Demitrack M 1997 Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psych Res 31:69-82
115. Nathan KI, Musselman DL, Schatzberg AF, Nemeroff CB 1995 Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, eds. Textbook of psychopharmacology. Washington DC: American Psychiatric Press
116. Nemeroff C 1996 The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336-342
117. Postemak MA, Zimmerman M 2002 Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psych 59:70-76
118. Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH 2002 Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 27:47-51
119. Anisman H, Ravindran AV, Griffiths J, Merali Z 1999 Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182-188
120. Geracioti TDJ, Loosen PT, Gold PW, Kling MA 1992 Cortisol, thyroid hormone, and mood in atypical depression: a longitudinal case study. Biol Psychiatry 31:515-519
121. Wilson A, Hickie I, Hadzi-Pavlovic D, Wakefield D, Parker G, Straus SE, Dale J, McCluskey D, Hinds G, Brickman A, Goldenberg D, Demitrack M, Blakely T, Wessely S, Sharpe M, Lloyd A 2001 What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry 35:520-527
122. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G 2001 Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 286:1360-1368
123. Cleare AJ 2003 The neuroendocrinology of chronic fatigue syndrome. Endocrine Abstracts 5:S35
124. Scott L, Dinan T 1999 Neuro-endocrine abnormalities in chronic fatigue syndrome: focus on the stress axis. Balliere's Clin Psychiatry 3:419-432
125. Cleare AJ, Wessely SC 1996 Chronic fatigue syndrome: a stress disorder? Br J Hosp Med 55:571-574
126. Parker AJR, Wessely S, Cleare AJ 2001 The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 31:1331-1345
127. Wallymahmed ME, Foy P, MacFarlane IA 1999 The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects. Clin Endocrinol (Oxf) 51:333-338
128. Vara Thorbeck R, Guerrero JA, Ruiz Requena E, Garcia Carriazo M 1996 Can the use of growth hormone reduce the postoperative fatigue syndrome? World J Surg 20:81-86
129. Allain TJ, Beam JA, Coskeran P, Jones J, Checkley A, Butler J, Wessely S, Miell JP 1997 Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 41:567-573
130. Berwaerts J, Moorkens G, Abs R 1998 Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res 8:127-129
131. Buchwald D, Umali J, Stene M 1996 Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol 23:739-742
132. Bennett AL, Mayes DM, Fagioli LR, Guerriero R, Komaroff AL 1997 Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndrome. J Psychiatr Res 31:91-96
133. Cleare AJ, Sookdeo SS, Jones J, O'Keane V, Miell JP 2000 Integrity of the growth hormone/insulin-like growth factor system is maintained in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 85:1433-1439
134. Dinan T 1998 Psychoneuroendocrinology of depression. Growth hormone. Psych Clin North Am 21:325-339
135. Moorkens G, Wynants H, Abs R 1998 Effect of growth hormone treatment in patients with chronic fatigue syndrome: a preliminary study. Growth Horm IGF Res 8:131-133
136. Korszun A, Sackett-Lundeen L, Papadopoulos E, Brucksch C, Masterson L, Engelberg NC, Haus E, Demitrack MA, Crofford L 1999 Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 26:2675-2680
137. Knook L, Kavelaars A, Sinnema G, Kuis W, Heijnen CJ 2000 High nocturnal melatonin in adolescents with chronic fatigue syndrome. J Clin Endocrinol Metab 85:3690-3692
138. Papadopoulos E, Crofford LJ, Engleberg NC, Korszun A, Brucksch C, Eisner S, Demitrack MA 1997 Impaired HPA axis activity in chronic fatigue syndrome and fibromyalgia. Biol Psychiatry 41:29S
139. Demitrack M, Crofford L 1998 Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Arm NY Acad Sci 840:684-697
140. Lascelles P, Evans P, Mersky H, Sabur M 1974 Plasma cortisol in psychiatric and neurological patients with pain. Brain 97:533-538
141. Carroll B, Curtis G, Mendels J 1976 Neuroendocrine regulation in depression. I: limbic system-adrenocortical dysfunction. Arch Gen Psych 33:1039-1044
142. Hamilos DL, Nutter D, Gershtenson J, Ikle D, Hamilos SS, Redmond DP, Di Clementi JD, Schmaling KB, Jones JF 2001 Circadian rhythm of core body temperature in subjects with chronic fatigue syndrome. Clin Physiol 21:184
143. Williams G, Pirohamed J, Minors O, Waterhouse J, Buchan I, Arendt J, Edwards R 1996 Dissociation of body temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome. Clin Physiol 16:327-337
144. McAllister-Williams RH, Ferrier IN, Young AH 1998 Mood and neuropsychological function in depression: the role of corticosteroids and serotonin. Psychol Med 28:573-584
145. De Kloet E, Sybesma H, Reul J 1986 Selective control by corticosterone of serotonin-1 receptors capacity in raphe-hippocampal system. Neuroendocrinology 42:513-521
146. Delbende C, Delarue C, Lefebvre H, Bunel DT, Szafarczyk A, Mocaer E, Kamoun A, Jegou S, Vaudry H 1992 Glucocorticoids, transmitters and stress. Br J Psychiatry Suppl 15:24-35
147. Checkley SA 1980 Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35-53
148. Bakheit A, Behan P, Dinan T, Gray C, O'Keane V 1992 Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Br Med J 304:1010-1012
149. Meltzer H, Gudelsky G, Lowy M, Nash J, Koenig J 1991 Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms. In: Tunnicliff G, Eison AS, Taylor OP, eds. Buspirone: mechanisms and clinical aspects. San Diego: Academic Press; 177-192
150. Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ 1995 Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry 38:235-239
151. Sharpe M, Clements A, Hawton K, Young A, Sargent P, Cowen P 1996 Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 41:71-76
152. Cowen PJ 1993 Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 16:0362-5664
153. Sharpe M, Hawton K, Clements A, Cowen PJ 1997 Increased brain serotonin function in men with chronic fatigue syndrome. Br Med J 315:164-165
154. Demitrack M, Gold P, Dale J, Krahan D, Kling M, Straus S 1992 Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psychiatry 32:1065-1077
155. Odagiri Y, Shimomitsu T, Iwane H, Katsumura T 1996 Relationships between exhaustive mood state and changes in stress hormones following an ultraendurance race. Int J Sports Med 17:325-331
156. Chaudhuri A, Majeed T, Dinan T, Behan PO 1997 Chronic fatigue syndrome: a disorder of central cholinergic neurotransmission. J Chronic Fatigue Syndrome 3:3-16
157. Candy B, Chalder T, Cleare AJ, Wessely S, White PD, Hotopf M 2002 Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract 52:844-851 (Review)
158. Salmon P, Hall GM 1997 A theory of postoperative fatigue: an interaction of biological, psychological, and social processes. Pharmacol Biochem Behav 56:623-628
159. Loge J, Abrahamsen A, Ekeberg O, Kaasa S 1999 Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 17:253-261
160. Sharpe M, Chalder T, Palmer I, Wessely S 1997 Chronic fatigue syndrome. A practical guide to assessment and management. Gen Hosp Psychiatry 19:185-199
161. Wittchen H-U, Pfister H 1997 DIA-X-Interviews. Frankfurt: Swets and Zeitlinger
162. Lewis G, Pelosi A, Araya R, Dunn G 1992 Measuring psychiatric disorder in the community: a standardized assessment for lay interviewer. Psychol Med 22:465-486
163. Cleare AJ, O'Keane V, Miell JP, Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology, in press